Hypercalcemic Ovarian Carcinoma (Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT)): A Case Series and Review of Literature of a Rare Malignancy

Young RH, Goodman A, Penson RT, Russell AH, Uppot RN, Tambouret RH (2010) Case records of the Massachusetts General Hospital. Case 8–2010. A 22-year-old woman with hypercalcemia and a pelvic mass. N Engl J Med 362:1031–40

Article  CAS  PubMed  Google Scholar 

Matias-Guiu X, Prat J, Young RH et al (1994) Human parathyroid hormone-related protein in ovarian small cell carcinoma: an immunohistochemical study. Cancer. 73:1878–81

Article  CAS  PubMed  Google Scholar 

Ramos P, Karnezis AN, Craig DW, Sekulic A, Russell ML, Hendricks WP et al (2014) Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4. Nat Genet 46:427–9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scully RE. Tumors of the ovary and maldeveloped gonads. In: Hartmann WH, Cowan WR (eds) Atlas of Tumor Pathology. Armed Forces Institute of Pathology, Washington, DC, pp 239–312

Kurman RJ, Carcangiu ML, Herrington CS, Young RH (eds) (2014) WHO Classification of Tumours of Female Reproductive Organs. IARC Press, Lyon

Clarke BA, Witkowski L, Ton Nu TN, Shaw PA, Gilks CB, Huntsman D et al (2016) Loss of SMARCA4 (BRG1) protein expression as determined by immunohistochemistry in small-cell carcinoma of the ovary, hypercalcaemic type distinguishes these tumours from their mimics. Histopathology 69:727–38

Article  PubMed  Google Scholar 

Seidman JD (1995) Small cell carcinoma of the ovary of the hypercalcemic type, p53 protein accumulation and clinicopathologic features. Gynecol Oncol 59:283–287

Article  CAS  PubMed  Google Scholar 

Schrader KA, Hurlburt J, Kalloger SE et al (2012) Germline BRCA1 and BRCA2 mutations in ovarian cancer: utility of a histology-based referral strategy. Obstet Gynecol 120:235–240

Article  CAS  PubMed  Google Scholar 

Jelinic P, Ricca J, Van Oudenhove E et al (2018) Immune-active microenvironment in small cell carcinoma of the ovary, hypercalcemic type: rationale for immune checkpoint blockade. J Natl Cancer Inst 110:787–790

Article  PubMed  PubMed Central  Google Scholar 

Witkowski L, Goudie C, Ramos P, Boshari T, Brunet JS, Karnezis AN et al (2016) The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type. Gynecol Oncol 141:454–60

Article  PubMed  PubMed Central  Google Scholar 

Ray-Coquard I, Morice P, Lorusso D, Prat J, Oaknin A, Pautier P et al (2018) Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 29:iv1-8

Article  CAS  PubMed  Google Scholar 

Pautier P, Ribrag V, Duvillard P, Rey A, Elghissassi I, Sillet-Bach I et al (2007) Results of a prospective dose-intensive regimen in 27 patients with small cell carcinoma of the ovary of the hypercalcemic type. Ann Oncol 18:1985–9

Article  CAS  PubMed  Google Scholar 

留言 (0)

沒有登入
gif